Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04843319
Title To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (VERU-100)
Acronym VERU-100
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Veru Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Urology Specialist Tucson Arizona 85704 United States Details
Urology Associates of Southern Arizona Tucson Arizona 85715 United States Details
San Bernardino Urological Associates San Bernardino California 92404 United States Details
Genesis Research, LLC San Diego California 92123 United States Details
Debbie Urology Johnson Jeffersonville Indiana 47130 United States Details
Chesapeake Urology Research Associates Towson Maryland 21204 United States Details
Clinical Research Solutions Middleburg Heights Ohio 44130 United States Details
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
Houston Metro Urology Houston Texas 77027 United States Details
Urology San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field